DENTSPLY SIRONA Inc. (NASDAQ:XRAY) finished Wednesday with a subtraction of -$0.06 to close at $30.78, a downside of -0.19 percent. An average of 3,179,580 shares of common stock have been traded in the last five days. There was a fall of -$1.78 in the past week, and it reached a new high 3 times over the past 12 months. The last 20 days have seen an average of 2,362,100 shares traded, while the 50-day average volume stands at 1,969,752.
XRAY stock has decreased by -10.70% in the last month. The company shares reached their 1-month lowest point of $30.58 on 09/20/22. With the stock rallying to its 52-week high on 02/25/22, shares of the company touched a low of $30.58 and a high of $61.18 in 52 weeks. It has reached a new high 4 times so far this year and lost -44.83% or -$25.01 in price. In spite of this, the price is down -49.69% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
142 days have passed since DENTSPLY SIRONA Inc. (XRAY) last reported insider trading activity. BRANDT ERIC, who is Director, most recently acquired $6,900 shares at $39.71 per share on May 03. In this transaction, the insider spent $273,999. Sr VP & Chief HR Officer, Yankie Lisa, disposed of 1,903 shares at a price of $52.63 on Nov 19. The insider now owns more than $100,155 worth of shares. Prior to that, Chief Commercial Officer Petersohn Walter went on to Sale 86,431 shares at $54.18 each on Nov 17. An amount of $4,682,610 was transacted.
DENTSPLY SIRONA Inc. (XRAY) has a trailing price-to-earnings (P/E) ratio of 18.31. The stock’s beta is 0.92. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.63, the price-to-book (PB) ratio at 1.33, and the price-to-cash flow ratio at 14.20.
The company has a payout ratio of 22.00%. The company’s most recent quarterly dividend payment was $0.1250 a share, without any change from last year. Its latest increase dividend $0.0150 reported on Thursday March 3 2022.
The quick ratio of DENTSPLY SIRONA Inc. for the three months ended March 30 was 1.10, and the current ratio was 1.50, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.38 and a total debt to equity ratio of 0.42 for the quarter ending March 30. Its gross profit as reported stood at $2.36 billion compared to revenue of $4.25 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, DENTSPLY SIRONA Inc.’s return on assets was 4.50%.
For the three-month period that ended March 30, DENTSPLY SIRONA Inc. had $1.91 billion in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $102.0 million in the quarter, while revenues were grew 47.25%. The analyst consensus anticipated DENTSPLY SIRONA Inc.’s latest quarter earnings to come in at $0.56 per share, but it turned out to be $0.52, a -7.10% surprise.
From a technical analysis perspective, let’s take a brief look at DENTSPLY SIRONA Inc. (XRAY) price momentum. RSI 9-day as of the close on 21 September was 30.15%, suggesting the stock is Neutral, with historical volatility in this time frame at 33.52%.
As of today, XRAY’s price is $31.71 -5.47% or -$1.78 from its 5-day moving average. XRAY is currently trading -10.26% lower than its 20-day SMA and -23.41% lower than its 100-day SMA. However, the stock’s current price level is -11.60% below the SMA50 and -39.31% below the SMA200.
The stochastic %K and %D were 12.66% and 23.02%, respectively, and the average true range (ATR) was 1.00. With the 14-day stochastic at 4.89% and the average true range at 0.99, the RSI (14) stands at 33.26%. The stock has reached -1.29 on the 9-day MACD Oscillator while the 14-day reading was at -1.11.
William Blair downgraded DENTSPLY SIRONA Inc. (NASDAQ: XRAY) to a an Underperform rating in its most recent analyst report. Previously, the stock was rated as a Mkt perform. The consensus rating for DENTSPLY SIRONA Inc. (XRAY) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell XRAY, while 4 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.
What is XRAY’s price target for the next 12 months?
Analysts predict a range of price targets between $38.00 and $51.00, with a median target of $41.50. Taking a look at these predictions, the average price target given by analysts for DENTSPLY SIRONA Inc. (XRAY) stock is $42.50.